P-BCMA-101 gains FDA regenerative medicine designationNovember 9, 2018Lymphoma & Plasma Cell Disorders
SRS beats surgery in early control of brain mets, advantage fades with timeNovember 9, 2018CNS/Brain CancerBreast CancerMelanomaGastroenterologyGenitourinary CancerRenal Cell CarcinomaGastrointestinal Cancer
Report details financial burden of blood cancersNovember 8, 2018Practice ManagementLeukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell Disorders
Variant not linked to CLL in Southeast EuropeNovember 7, 2018Leukemia, Myelodysplasia, Transplantation
ICYMI: Elotuzumab reduces progression risk in lenalidomide-refractory multiple myelomaNovember 7, 2018Lymphoma & Plasma Cell Disorders
